Browse drugs

…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…

…Background For over 30 years, microbial immunotherapy with Bacillus Calmette-Guérin (BCG) has been the standard-of-care for non-muscle invasive bla…

…accine10 11(in the US in 2014 and 2019) and fatal outcomes from muscle relaxant used as a diluent for vaccine preparation (in Syria in 2014 and…

…unctionality, and synergizes with immune checkpoint inhibitors. HCW11-006 represents a promising immunotherapeutic agent capable of induc…

…lude studies on intravesical instillation therapies with BCG or Mitomycin C for non-muscle-invasive bladder cancer, as well as studies that…

…d folic acid supplementation among pregnant women and uptake of BCG, Hepatitis B birth dose and Measles vaccines among children, wi…

…, Ali J, et al. Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.…

…Background Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy remains the cornerstone for managing high-r…

…vesical co-delivery of doxorubicin (DOX) and the TLR7/8 agonist IMDQ. This nanosystem localizes within the bladder wall and responds…

…he UPPL1541 cell line, and James M. McKiernan for providing the BCG vials. We are thankful for insightful discussion with the membe…

… increase in basic child vaccination coverage (one dose of BCG (Bacille Calmette-Guérin) and measles, and three doses of DTP (diphtheria, tetanus and p…